AVAH Valuation
Aveanna Healthcare Holdings Inc
$
7.670
- Overview
- Forecast
- Valuation
- Earnings
AVAH Relative Valuation
AVAH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AVAH is overvalued; if below, it's undervalued.
Historical Valuation
Aveanna Healthcare Holdings Inc (AVAH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.66 is considered Fairly compared with the five-year average of 41.45. The fair price of Aveanna Healthcare Holdings Inc (AVAH) is between 4.44 to 9.69 according to relative valuation methord.
Relative Value
Fair Zone
4.44-9.69
Current Price：7.58
Fair
19.42
PE
1Y
3Y
5Y
Trailing
Forward
11.21
EV/EBITDA
Aveanna Healthcare Holdings Inc. (AVAH) has a current EV/EBITDA of 11.21. The 5-year average EV/EBITDA is 12.56. The thresholds are as follows: Strongly Undervalued below 9.12, Undervalued between 9.12 and 10.84, Fairly Valued between 14.28 and 10.84, Overvalued between 14.28 and 16.00, and Strongly Overvalued above 16.00. The current Forward EV/EBITDA of 11.21 falls within the Historic Trend Line -Fairly Valued range.
11.04
EV/EBIT
Aveanna Healthcare Holdings Inc. (AVAH) has a current EV/EBIT of 11.04. The 5-year average EV/EBIT is 14.14. The thresholds are as follows: Strongly Undervalued below 9.67, Undervalued between 9.67 and 11.90, Fairly Valued between 16.38 and 11.90, Overvalued between 16.38 and 18.62, and Strongly Overvalued above 18.62. The current Forward EV/EBIT of 11.04 falls within the Undervalued range.
0.66
PS
Aveanna Healthcare Holdings Inc. (AVAH) has a current PS of 0.66. The 5-year average PS is 0.39. The thresholds are as follows: Strongly Undervalued below -0.18, Undervalued between -0.18 and 0.11, Fairly Valued between 0.68 and 0.11, Overvalued between 0.68 and 0.96, and Strongly Overvalued above 0.96. The current Forward PS of 0.66 falls within the Historic Trend Line -Fairly Valued range.
16.29
P/OCF
Aveanna Healthcare Holdings Inc. (AVAH) has a current P/OCF of 16.29. The 5-year average P/OCF is 12.22. The thresholds are as follows: Strongly Undervalued below -223.51, Undervalued between -223.51 and -105.65, Fairly Valued between 130.08 and -105.65, Overvalued between 130.08 and 247.95, and Strongly Overvalued above 247.95. The current Forward P/OCF of 16.29 falls within the Historic Trend Line -Fairly Valued range.
18.72
P/FCF
Aveanna Healthcare Holdings Inc. (AVAH) has a current P/FCF of 18.72. The 5-year average P/FCF is 15.18. The thresholds are as follows: Strongly Undervalued below -280.97, Undervalued between -280.97 and -132.90, Fairly Valued between 163.25 and -132.90, Overvalued between 163.25 and 311.32, and Strongly Overvalued above 311.32. The current Forward P/FCF of 18.72 falls within the Historic Trend Line -Fairly Valued range.
Aveanna Healthcare Holdings Inc (AVAH) has a current Price-to-Book (P/B) ratio of -138.14. Compared to its 3-year average P/B ratio of -18.02 , the current P/B ratio is approximately 666.46% higher. Relative to its 5-year average P/B ratio of -11.71, the current P/B ratio is about 1079.19% higher. Aveanna Healthcare Holdings Inc (AVAH) has a Forward Free Cash Flow (FCF) yield of approximately 5.03%. Compared to its 3-year average FCF yield of -7.22%, the current FCF yield is approximately -169.70% lower. Relative to its 5-year average FCF yield of -5.44% , the current FCF yield is about -192.50% lower.
-137.40
P/B
Median3y
-18.02
Median5y
-11.71
5.03
FCF Yield
Median3y
-7.22
Median5y
-5.44
Competitors Valuation Multiple
The average P/S ratio for AVAH's competitors is 1.30, providing a benchmark for relative valuation. Aveanna Healthcare Holdings Inc Corp (AVAH) exhibits a P/S ratio of 0.66, which is -49.34% above the industry average. Given its robust revenue growth of 16.75%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of AVAH increased by 35.75% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 2.75 to 4.58.
The secondary factor is the Revenue Growth, contributed 16.75%to the performance.
Overall, the performance of AVAH in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
COGT
Cogent Biosciences Inc
12.230
USD
+3.73%
UAN
CVR Partners LP
90.860
USD
+0.61%
REAX
Real Brokerage Inc
5.130
USD
+2.40%
BXC
Bluelinx Holdings Inc
83.640
USD
-1.02%
NESR
National Energy Services Reunited Corp
8.720
USD
+1.28%
AVO
Mission Produce Inc
12.460
USD
-0.80%
KRUS
Kura Sushi USA Inc
79.760
USD
+1.41%
UTL
Unitil Corp
46.590
USD
-0.49%
BFS
Saul Centers Inc
33.760
USD
+0.51%
GRNT
Granite Ridge Resources Inc
5.670
USD
-0.70%
FAQ
Is Aveanna Healthcare Holdings Inc (AVAH) currently overvalued or undervalued?
Aveanna Healthcare Holdings Inc (AVAH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.66 is considered Fairly compared with the five-year average of 41.45. The fair price of Aveanna Healthcare Holdings Inc (AVAH) is between 4.44 to 9.69 according to relative valuation methord.
What is Aveanna Healthcare Holdings Inc (AVAH) fair value?
How does AVAH's valuation metrics compare to the industry average?
What is the current P/B ratio for Aveanna Healthcare Holdings Inc (AVAH) as of Aug 27 2025?
What is the current FCF Yield for Aveanna Healthcare Holdings Inc (AVAH) as of Aug 27 2025?
What is the current Forward P/E ratio for Aveanna Healthcare Holdings Inc (AVAH) as of Aug 27 2025?
